Associated Papers
Comprehensive analysis of the deleterious nonsynonymous, non-coding SNPs and cancer variants of human aldo-keto reductase type 1 (AKR1C1) protein and their probable association with disease risk and progression: a computational study.
Nila NN et al.
Biochemistry and Biophysics Reports, 2026
Large-scale whole-exome sequencing analyses identified protein-coding variants associated with immune-mediated diseases in 350,770 adults.
Yang L et al.
Nature Communications, 2024
39009607 (PubMed )
Supplement: 41467_2024_49782_MOESM4_ESM.xlsx › Supplementary_Data_18
In Vitro Evaluation of the Reductase Activities of Human AKR1C3 Allelic Variants.
Takano S et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2023
Pharmacogenetics of aldo-keto reductase 1C (AKR1C) enzymes.
Alshogran OY
Expert Opinion on Drug Metabolism & Toxicology, 2017
Modeling single nucleotide polymorphisms in the human AKR1C1 and AKR1C2 genes: implications for functional and genotyping analyses.
Arthur JW et al.
Plos One, 2010
Select a paper to view details